| 03.05 14:31 | dpa-AFX: EQS-Stimmrechte: Evotec SE (english) |
| 03.05 14:31 | dpa-AFX: EQS-Public Voting Rights: Evotec SE (english) |
| 03.05 14:31 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 03.05 14:31 | EQS-PVR: Evotec SE: Release according to Article -2- |
| 03.05 14:31 | EQS-PVR: Evotec SE: Release according to Article -3- |
| 03.05 14:30 | dpa-AFX: EQS-Stimmrechte: Evotec SE (english) |
| 03.05 14:30 | dpa-AFX: EQS-Public Voting Rights: Evotec SE (english) |
| 03.05 14:30 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 03.05 14:28 | dpa-AFX: EQS-Stimmrechte: Evotec SE (english) |
| 03.05 14:28 | dpa-AFX: EQS-Public Voting Rights: Evotec SE (english) |
| 03.05 14:28 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 03.05 13:49 | dpa-AFX: EQS-Public Voting Rights: Evotec SE (english) |
| 03.05 13:49 | dpa-AFX: EQS-Stimmrechte: Evotec SE (english) |
| 03.05 13:49 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 03.05 10:21 | dpa-AFX: ANALYSE-FLASH: RBC senkt Ziel für Evotec auf 16 Euro - 'Outperform' |
| 03.05 10:21 | dpa-AFX: RBC senkt Ziel für Evotec auf 16 Euro - 'Outperform' |
| 03.05 06:53 | dpa-AFX: *RBC CUTS EVOTEC PRICE TARGET TO 16.00 (18.60) EUR - 'OUTPERFORM' |
| 03.05 06:53 | dpa-AFX: *RBC SENKT ZIEL FÜR EVOTEC AUF 16,00 (18,60) EUR - 'OUTPERFORM' |
| 30.04 09:11 | Bayer kooperiert mit Evotec in Forschung zu Präzisionskardiologie |
| 30.04 08:32 | dpa-AFX: *EVOTEC: FINANZIELLE DETAILS DER VEREINBARUNG WERDEN NICHT VERÖFFENTLICHT |
|
|
